74 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical Trials

OBJECTIVES/GOALS: To describe the impact of Trial-CARE (Coordination, Acceleration, and Recruitment Enhancement), a centralized service core at Washington University (WU), aimed at enhancing the capability of investigator-initiated multi-site clinical trials at WU and partner CTSA institutions. METH...

Full description

Bibliographic Details
Main Authors: Katie Keenoy, Suresh Vedantham, Emily Lake
Format: Article
Language:English
Published: Cambridge University Press 2024-04-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866124000761/type/journal_article
_version_ 1797226925036404736
author Katie Keenoy
Suresh Vedantham
Emily Lake
author_facet Katie Keenoy
Suresh Vedantham
Emily Lake
author_sort Katie Keenoy
collection DOAJ
description OBJECTIVES/GOALS: To describe the impact of Trial-CARE (Coordination, Acceleration, and Recruitment Enhancement), a centralized service core at Washington University (WU), aimed at enhancing the capability of investigator-initiated multi-site clinical trials at WU and partner CTSA institutions. METHODS/STUDY POPULATION: Through review of our marketing materials and service tracking system we defined the following Trial-CARE offerings: Infrastructure: Trial-CARE is a centralized service core at WU. Whereby, a team member is sourced to an investigator-initiated multi-site clinical trial (II-MCT) to ensure the achievement of study milestones across any phase of the clinical trial life cycle. Team: Our team consists of research professionals with expertise in II-MCT project management, data management, and administrative/regulatory management. Services: * One free 60-minute case consultation * Tiers of Service * Academic Research Organization (ARO) support * Clinical Coordinating Center * Data Coordinating Center * II-MCT project management support * Time-limited targeted support RESULTS/ANTICIPATED RESULTS: Trial-CARE has completed 94 consultations in support of WU and partner CTSA institutions enabling the streamlining of study start-up; guidance for study recruitment, implementation, and operations; and offering resources to foster career development. Consultations can be completed at any phase in the clinical trial lifecycle, with Trial-CARE completing: * 12% in the idea phase * 45% in the grant development and submission stage * 28% after funding has been awarded Top reasons researchers connect with Trial-CARE about II-MCTs: * regulatory guidance (40%) * general information about Trial-CARE Services and II-MCTs (35%) * protocol development (21%) * data management (20%) * study budgeting (20%) DISCUSSION/SIGNIFICANCE: In response to a WU wide survey, Trial-CARE plans to generate informational webinars and is creating a clinical trial tracking dashboard, to pro-actively offer support services to researchers prior to grant funding. The goal is also to increase the percentage of consultations completed in the idea phase and the grant development and submission stage.
first_indexed 2024-04-24T14:32:39Z
format Article
id doaj.art-f88be96ecc80468f9cc321ed96153b34
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-24T14:32:39Z
publishDate 2024-04-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-f88be96ecc80468f9cc321ed96153b342024-04-03T02:00:11ZengCambridge University PressJournal of Clinical and Translational Science2059-86612024-04-018191910.1017/cts.2024.7674 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical TrialsKatie Keenoy0Suresh Vedantham1Emily Lake2Washington University in St. LouisWashington University in St. LouisWashington University in St. LouisOBJECTIVES/GOALS: To describe the impact of Trial-CARE (Coordination, Acceleration, and Recruitment Enhancement), a centralized service core at Washington University (WU), aimed at enhancing the capability of investigator-initiated multi-site clinical trials at WU and partner CTSA institutions. METHODS/STUDY POPULATION: Through review of our marketing materials and service tracking system we defined the following Trial-CARE offerings: Infrastructure: Trial-CARE is a centralized service core at WU. Whereby, a team member is sourced to an investigator-initiated multi-site clinical trial (II-MCT) to ensure the achievement of study milestones across any phase of the clinical trial life cycle. Team: Our team consists of research professionals with expertise in II-MCT project management, data management, and administrative/regulatory management. Services: * One free 60-minute case consultation * Tiers of Service * Academic Research Organization (ARO) support * Clinical Coordinating Center * Data Coordinating Center * II-MCT project management support * Time-limited targeted support RESULTS/ANTICIPATED RESULTS: Trial-CARE has completed 94 consultations in support of WU and partner CTSA institutions enabling the streamlining of study start-up; guidance for study recruitment, implementation, and operations; and offering resources to foster career development. Consultations can be completed at any phase in the clinical trial lifecycle, with Trial-CARE completing: * 12% in the idea phase * 45% in the grant development and submission stage * 28% after funding has been awarded Top reasons researchers connect with Trial-CARE about II-MCTs: * regulatory guidance (40%) * general information about Trial-CARE Services and II-MCTs (35%) * protocol development (21%) * data management (20%) * study budgeting (20%) DISCUSSION/SIGNIFICANCE: In response to a WU wide survey, Trial-CARE plans to generate informational webinars and is creating a clinical trial tracking dashboard, to pro-actively offer support services to researchers prior to grant funding. The goal is also to increase the percentage of consultations completed in the idea phase and the grant development and submission stage.https://www.cambridge.org/core/product/identifier/S2059866124000761/type/journal_article
spellingShingle Katie Keenoy
Suresh Vedantham
Emily Lake
74 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical Trials
Journal of Clinical and Translational Science
title 74 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical Trials
title_full 74 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical Trials
title_fullStr 74 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical Trials
title_full_unstemmed 74 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical Trials
title_short 74 Trial-CARE: Centralized Support Services for Investigator-Initiated Multi-Site Clinical Trials
title_sort 74 trial care centralized support services for investigator initiated multi site clinical trials
url https://www.cambridge.org/core/product/identifier/S2059866124000761/type/journal_article
work_keys_str_mv AT katiekeenoy 74trialcarecentralizedsupportservicesforinvestigatorinitiatedmultisiteclinicaltrials
AT sureshvedantham 74trialcarecentralizedsupportservicesforinvestigatorinitiatedmultisiteclinicaltrials
AT emilylake 74trialcarecentralizedsupportservicesforinvestigatorinitiatedmultisiteclinicaltrials